Rafal Dziadziuszko

8PUBLICATIONS
72CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 26, 2026
Prognostic Role of 18F-FDG PET/CT in Oligometastatic Non-Small Cell Lung Cancer: Preliminary Results from Single Center.

|Jan 13, 2026
Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer.

Glenwood D Goss, Gail E Darling, Virginie Westeel

|Jan 09, 2026
TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden-High Tumors.

David M Thomas, Jeong Eun Kim, Fabrice Barlesi

|Jul 09, 2025
Single-Agent Divarasib in Patients With KRAS G12C-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study.

Adrian G Sacher, Wilson H Miller, Manish R Patel

|May 24, 2024
Moving Immunotherapy Into the Treatment of Resectable Non-Small Cell Lung Cancer.

Jamie E Chaft, Rafal Dziadziuszko, Bernardo Haddock Lobo Goulart

|Mar 11, 2022
Circulating Cell-free DNA as a Prognostic Biomarker in Patients with Advanced ALK+ Non-small Cell Lung Cancer in the Global Phase III ALEX Trial.

Rafal Dziadziuszko, Solange Peters, Tony Mok

Pageof 2

Frequent Collaborators

1 joint publications

Monika Tomaszewska-Kiecana

1 joint publications

Rodryg Ramlau

1 joint publications

Yvette Drew

1 joint publications

Milada Zemanova